BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29447268)

  • 1. Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
    Lopes AP; Hillen MR; Chouri E; Blokland SLM; Bekker CPJ; Kruize AA; Rossato M; van Roon JAG; Radstake TRDJ
    PLoS One; 2018; 13(2):e0193157. PubMed ID: 29447268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
    Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
    Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proportion of a CD38
    Ishioka-Takei E; Yoshimoto K; Suzuki K; Nishikawa A; Yasuoka H; Yamaoka K; Takeuchi T
    Clin Immunol; 2018 Feb; 187():85-91. PubMed ID: 29061446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
    Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
    Pertovaara M; Silvennoinen O; Isomäki P
    Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.
    Björk A; Thorlacius GE; Mofors J; Richardsdotter Andersson E; Ivanchenko M; Tingström J; James T; Brokstad KA; Cox RJ; Jonsson R; Kvarnström M; Wahren-Herlenius M
    Rheumatology (Oxford); 2020 Jul; 59(7):1651-1661. PubMed ID: 31665501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution.
    Szabó K; Jámbor I; Szántó A; Horváth IF; Tarr T; Nakken B; Szodoray P; Papp G
    Front Immunol; 2021; 12():639975. PubMed ID: 33815392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
    Zhang R; Sun T; Song L; Zuo D; Xiao W
    Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.